Third Arc Bio
Series AThird Arc Bio is a privately held company based in United States, founded in 2022. The latest disclosed round is Series A ($52m), dated Feb 04, 2026. Institutional investors on record include Andreessen Horowitz.
United States · EST 2022
What is Third Arc Bio?
Third Arc Bio is a privately held company based in United States, founded in 2022. The latest disclosed round is Series A ($52m), dated Feb 04, 2026. Institutional investors on record include Andreessen Horowitz. Developer of therapetics for cancer and immunological diseases. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Third Arc Bio?
Who invested in Third Arc Bio?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Andreessen Horowitz | Series A | $52m | Feb 04, 2026 |
What do founders ask about Third Arc Bio?
What is Third Arc Bio?
Third Arc Bio is a privately held company based in United States, founded in 2022. The latest disclosed round is Series A ($52m), dated Feb 04, 2026. Institutional investors on record include Andreessen Horowitz. Developer of therapetics for cancer and immunological diseases. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Third Arc Bio's last funding round?
Third Arc Bio's latest disclosed round is Series A at $52m (Feb 04, 2026).
Who invested in Third Arc Bio?
Third Arc Bio has 1 institutional investors on this page, including Andreessen Horowitz.
How does CrackTheDeck cover Third Arc Bio?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Third Arc Bio card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.